Lung epithelial binding peptide-linked high mobility group box-1 A box for lung epithelial cell-specific delivery of DNA

Journal of Drug Targeting

Volumn 19, Issue 7, 2011, Pages 589-596

  Kim, Hyun Ah ^a   Park, Ji Hwan ^a   Cho, Su Hee ^a   Lee, Minhyung ^a  

^a Hanyang University   (South Korea)

Author keywords

Gene delivery; High mobility group box 1; Lung epithelial cells; Recombinant peptide

Indexed keywords

BINDING PROTEIN; DNA; DRUG CARRIER; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP BOX 1A PROTEIN; LUNG EPITHELIAL BINDING PEPTIDE; POLYETHYLENEIMINE; PROTON; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; ASSAULT; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA; DNA PRIMERS; EPITHELIAL CELLS; HMGB1 PROTEIN; LUNG; RATS;

EID: 79960521622     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.547584     Document Type: Article

References (31)

1. Agu RU, Ugwoke MI, Armand M, Kinget R, Verbeke N. (2001). The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir Res, 2, 198-209. (Pubitemid 34187927)
2. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. (2002). HMGB1 as a DNA-binding cytokine. J Leukoc Biol, 72, 1084-1091. (Pubitemid 36008878)
3. Andersson UG, Tracey KJ. (2004). HMGB1, a pro-inflammatory cytokine of clinical interest: introduction. J Intern Med, 255, 318-319. (Pubitemid 38315273)
4. Bewley CA, Gronenborn AM, Clore GM. (1998). Minor groove-binding architectural proteins: structure, function, and DNA recognition. Annu Rev Biophys Biomol Struct, 27, 105-131. (Pubitemid 28286011)
5. Fischer D, Bieber T, Li Y, Elsässer HP, Kissel T. (1999). A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res, 16, 1273-1279. (Pubitemid 29393618)
6. Frost RA, Nystrom G, Burrows PV, Lang CH. (2005). Temporal differences in the ability of ethanol to modulate endotoxininduced increases in inflammatory cytokines in muscle under in vivo conditions. Alcohol Clin Exp Res, 29, 1247-1256. (Pubitemid 41060441)
7. Gautam A, Waldrep JC, Densmore CL. (2003). Aerosol gene therapy. Mol Biotechnol, 23, 51-60. (Pubitemid 36106223)
8. Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Lee DC, Ward MF, Bruchfeld AN, Wang H, Lesser ML, Church AL, Litroff AH, Sama AE, Tracey KJ. (2006). Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock, 25, 571-574. (Pubitemid 44297016)
9. Gong Q, Xu JF, Yin H, Liu SF, Duan LH, Bian ZL. (2009). Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice. Scand J Immunol, 69, 29-35.
10. Han JS, Kim K, Lee M. (2009). A high mobility group B-1 box A peptide combined with an artery wall binding peptide targets delivery of nucleic acids to smooth muscle cells. J Cell Biochem, 107, 163-170.
11. Han S, Mahato RI, Sung YK, Kim SW. (2000). Development of biomaterials for gene therapy. Mol Ther, 2, 302-317.
12. Kang HC, Lee M, Bae YH. (2005). Polymeric gene carriers. Crit Rev Eukaryot Gene Expr, 15, 317-342.
13. Kim JB, Choi JS, Yu YM, Nam K, Piao CS, Kim SW, Lee MH, Han PL, Park JS, Lee JK. (2006). HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci, 26, 6413-6421. (Pubitemid 44318322)
14. Kim K, Han JS, Kim HA, Lee M. (2008a). Expression, purification and characterization of TAT-high mobility group box-1A peptide as a carrier of nucleic acids. Biotechnol Lett, 30, 1331-1337.
15. Kim K, Han JS, Park JH, Ko KS, Lee M. (2008b). Expression and characterization of a recombinant high mobility group box 1 AB peptide with a 6-histidine tag for delivery of nucleic acids. Enzyme Microbial Technol, 43, 410-416.
16. Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T, Ishino M, Bilim O, Nakajima O, Kubota I. (2008). High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res, 80, 40-46.
17. Kokkola R, Li J, Sundberg E, Aveberger AC, Palmblad K, Yang H, Tracey KJ, Andersson U, Harris HE. (2003). Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum, 48, 2052-2058. (Pubitemid 36828701)
18. Lee M, Kim SW. (2002). Polymeric gene carriers. Pharm News, 9, 407-415. (Pubitemid 37107970)
19. Lee M, Nah JW, Kwon Y, Koh JJ, Ko KS, Kim SW. (2001). Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm Res, 18, 427-431. (Pubitemid 32592572)
20. Lee M, Rentz J, Han SO, Bull DA, Kim SW. (2003). Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther, 10, 585-593. (Pubitemid 36432610)
21. Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X, Harris HE, Czura CJ, Wang H, Ulloa L, Wang H, Warren HS, Moldawer LL, Fink MP, Andersson U, Tracey KJ, Yang H. (2003). Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med, 9, 37-45. (Pubitemid 36667690)
22. Niidome T, Huang L. (2002). Gene therapy progress and prospects: nonviral vectors. Gene Ther, 9, 1647-1652. (Pubitemid 36104607)
23. Pullerits R, Jonsson IM, Verdrengh M, Bokarewa M, Andersson U, Erlandsson-Harris H, Tarkowski A. (2003). High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum, 48, 1693-1700. (Pubitemid 36682378)
24. Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, Salomone S, Moskowitz MA. (2008). Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab, 28, 927-938. (Pubitemid 351589627)
25. Shen Y, Peng H, Deng J, Wen Y, Luo X, Pan S, Wu C, Feng M. (2009). High mobility group box 1 protein enhances polyethylenimine mediated gene delivery in vitro. Int J Pharm, 375, 140-147.
26. Suzuki M, Matsuse T, Isigatsubo Y. (2001). Gene therapy for lung diseases: development in the vector biology and novel concepts for gene therapy applications. Curr Mol Med, 1, 67-79. (Pubitemid 33772970)
27. Thomas JO. (2001). HMG1 and 2: architectural DNA-binding proteins. Biochem Soc Trans, 29, 395-401.
28. Wang H, Zhu S, Zhou R, Li W, Sama AE. (2008). Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med, 10, e32.
29. Wu M, Pasula R, Smith PA, Martin WJ 2nd. (2003). Mapping alveolar binding sites in vivo using phage peptide libraries. Gene Ther, 10, 1429-1436. (Pubitemid 36987136)
30. Yang H, Wang H, Czura CJ, Tracey KJ. (2002). HMGB1 as a cytokine and therapeutic target. J Endotoxin Res, 8, 469-472.
31. Zhang CL, Shu MG, Qi HW, Li LW. (2008). Inhibition of tumor angiogenesis by HMGB1 A box peptide. Med Hypotheses, 70, 343-345.